Company intelligence / Profile preview
Milo Biotechnology
Cleveland, Ohio, United Statesmilobiotechnology.com ↗
- Ownership
- Private
- Employees
- ~25
- Development stage
- Other
01
Overview
Milo Biotechnology develops an adeno-associated virus (AAV) gene therapy delivering the follistatin protein to enhance muscle strength and reduce inflammation/fibrosis. Their lead program, AAV1-FS344, has advanced into Phase I/II trials targeting rare neuromuscular diseases such as Becker muscular dystrophy and inclusion body myositis. Early results indicate potential for increased muscle mass and function with a favorable safety profile in these populations.
- Therapeutic areas
- Rare DiseasesNeurology
- Modalities
- Gene therapy (AAV-mediated delivery)Protein therapy (follistatin)
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Technology exclusively licensed from Nationwide Children’s HospitalJumpStart Inc. (funding)Cuyahoga County North Coast Opportunities Fund (funding)NIAMS Rare Disease SBIR program (funding)Rev1 Ventures (funding)Duchenne Alliance (funding)
Beyond the preview
Go deeper on Milo Biotechnology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Milo Biotechnology.